Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

iToBoS

Financiado

Cerrado

Intelligent Total Body Scanner for Early Detection of Melanoma

Melanoma is one of the most aggressive cancers that can be discovered at an early stage, and it is responsible for 60% of lethal skin neoplasia. Its incidence has been increasing in white population and could become a public healt... ver más

31/03/2025

UDG

12M€

Presupuesto del proyecto: 12M€

Líder del proyecto

UNIVERSITAT DE GIRONA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 232

Fecha límite participación Sin fecha límite de participación.

Ver 24 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2025-03-31

SC1-BHC-06-2020: Digital diagnostics – developing to... Specific Challenge:The availability of appropriate decision support tools for healthcare practitione...

I+D

Cerrada hace 4 años

0% 97% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

24 Participantes

UDG

1.13M€ | Lider

FRECARN

324.81K€ | Participante

IBM ISRAEL - SCIENCE AND TE...

Optotune

504.68K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 50 meses Fecha Inicio: 2021-01-29
Fecha Fin: 2025-03-31

Líder del proyecto

UNIVERSITAT DE GIRONA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 232

Presupuesto del proyecto 12M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Melanoma is one of the most aggressive cancers that can be discovered at an early stage, and it is responsible for 60% of lethal skin neoplasia. Its incidence has been increasing in white population and could become a public health challenge because of an increase in life expectancy of the elderly population. Total body skin examination, the primary screening mechanism for melanoma, checks each pigmented skin lesion individually in search of typical melanoma signs. This can be a very time consuming technique for patients with atypical mole syndrome or a large number of naevi. iToBoS aims at developing an AI diagnostic platform for early detection of melanoma. The platform includes a novel total body scanner and a Computer Aided Diagnostics (CAD) tool to integrate various data sources such as medical records, genomics data and in vivo imaging. This approach will lead to a highly patient-tailored, early diagnosis of melanoma. The project will develop and validate an AI cognitive assistant tool to empower healthcare practitioners, offering a risk assessment for every mole. Beyond integrating all available information about the patient to personalise the diagnostic, it will provide methods for visualising, explaining and interpreting AI models, thus overcoming the black box nature of current AI-enabled CAD systems, and providing dermatologists with valuable information for their clinical practice. The new total body scanner will be based on an existing prototype developed by 3 of the project partners, but powered with high-resolution cameras equipped with liquid lenses. These novel lenses, based on two immiscible fluids of different refractive index, will allow achieving unprecedented image quality of the whole body. The integration of such images with all available patient data using machine learning will lead to a new dermoscopic diagnostic tool providing prompt, reliable and highly personalised diagnostics for optimal judgement in clinical practice.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores